Twenty-two patients treated with anthracycline-based regimens were eligible. Out of the 22 patients, 8 received chemotherapy (CT) only (subgroup 1), while 14 underwent RT after CT [subgroup 2 (S2)]. At the end of CT, ejection fraction was significantly reduced in the whole population. At ...
The EBCTCG overview of 60 trials of prolonged polychemotherapyvsno chemotherapy involving 36 000 women has confirmed that, adjuvant anthracycline-based chemotherapy reduces the annual odds of death by 38% (s.e.=5), for women under 50 years of age at diagnosis and by 20% (s.e.=4) in ...
aTaxane and anthracycline based neoadjuvant chemotherapy for locally advanced breast cancer : institutional experience. Taxane 和 anthracycline 设立本地被推进的乳腺癌的新辅佐的化疗:制度上的经验。[translate] aThe results of this study increase understanding the properties of recycled vegetable oils and their...
Treatment of Refractory Adult Acute Lymphocytic Leukaemia and Acute Undifferentiated Leukaemia with an Anthracycline Antibiotic and Cytosine Arabinoside Myelosuppression and infection were the most significant complications of therapy. The data presented indicate that marrow ablative chemotherapy with an anthracycli...
Breast cancer is one of the leading causes of cancer mortality in women in developed countries even though most women with the disease die of other causes. Postoperative adjuvant chemotherapy with anthracycline-based regimens has been proven to decrease the risk of relapse and cancer-related mortality...
aNeoadjuvant bevacizumab and anthracycline-taxane-based chemotherapy in 678 triple-negative primary breast cancers; results from the geparquinto study (GBG 44). Neoadjuvant bevacizumab和基于anthracycline taxane的化疗在678三倍消极主要乳腺癌; 结果从geparquinto研究 (GBG 44)。[translate] ...
It is used mainly for the treatment of breast, ovarian, prostate, and non-small cell lung cancer. Docetaxel has an FDA approved claim for treatment of patients who have locally advanced, or metastatic breast or non small-cell lung cancer who have undergone anthracycline-based chemotherapy and ...
+1 250 565 2500 Email suresh.katakkar@northernhealth.ca Case history Our patient was in triple negative stage II and treated with anthracycline- and taxane- based chemotherapy, but when it metastasized, it showed Her2 positive cancer cells in the CNS location and triple negative features in the...
The most commonly used neoadjuvant chemotherapeutic regimen is the combination of cyclophosphamide, anthracycline, and taxane derivatives. Development of Focal Nodular Hyperplasia after Cyclophosphamide-Based Chemotherapy in a Patient with Breast Cancer As a result, the patient was given intravenous cyclophospha...
Diffuse pulmonary hemorrhage is an uncommon complication with former chemotherapy regimens, but has become more common with the introduction of new MTT and anti-angiogenic agents. Pulmonary hemorrhage and hemoptysis have been reported in 2.3% of patients with nonsquamous NSCLC on bevacizumab (Avastin) ...